Results 1 to 10 of about 11,222 (199)

Efficacy and safety of fluticasone propionate/formoterol fumarate in pediatric asthma patients: a randomized controlled trial [PDF]

Therapeutic Advances in Respiratory Disease, 2018
Background: The efficacy and safety of fluticasone propionate/formoterol fumarate pressurized metered-dose inhaler (pMDI) (fluticasone/formoterol; Flutiform ® ; 100/10 µg b.i.d.) was compared with fluticasone propionate (Flixotide ® Evohaler ® pMDI; 100 ...
Anna Płoszczuk, Miroslava Bosheva, Kay Spooner, Tammy McIver, Sanjeeva Dissanayake   +4 more
doaj   +2 more sources

Bioequivalence study of fluticasone propionate nebuliser suspensions in healthy Chinese subjects [PDF]

Frontiers in Pharmacology
BackgroundFluticasone propionate is a synthetic trifluoro-substituted glucocorticoid, a highly selective glucocorticoid receptor agonist. Fluticasone propionate nebuliser suspensions is an inhaled corticosteroid with the low systemic bioavailability ...
Feng Cheng, Tao Shen, Fucheng Zhang, Chenghao Lei, Ye Zhu, GuoJun Luo, Dawei Xiao   +6 more
doaj   +2 more sources

Fluticasone Propionate, 100 µg bid, Using a Non-CFC Propellant, HFA 134a, in Asthmatic Children [PDF]

Canadian Respiratory Journal, 2003
BACKGROUND: Secondary to phasing out chlorofluorocarbons (CFCs), the fluticasone propionate (FP) pressurized metered-dose inhaler has been formulated in a nonozone-depleting propellant, hydrofluoralkane (HFA) 134a.
Brian Lyttle, John Gillies, Maarja Panov, Andrzej Emeryk, Claire Wixon   +4 more
doaj   +2 more sources

Comparative efficacy of inhaled corticosteroids and leukotriene modifiers depending on ASP299GLY-TLR-4 polymorphism in patients with bronchial asthma in the population of AR Crimea. [PDF]

Medičnì Perspektivi, 2015
The study included 39 patients with bronchial asthma. All patients at baseline were stratified into two groups with the genotype AA and AG of polymorphism Asp299Gly TLR-4.
Yu. A. Bisyuk, A. I. Kurchenko, A. I. Dubovyi, V. E. Kondratiuk   +3 more
doaj   +2 more sources

The effect of treatment with fexofenadine and fluticasone propionate on the gene expression levels of Th9 transcription factors in patients with allergic rhinitis

Heliyon, 2021
T helper-9 (Th9) is a new T cell subset involved in allergic rhinitis (AR) pathogenesis. Fexofenadine and fluticasone propionate are the first effective line of AR treatment.
Ali asghar Askari, Parisa Feizollahi, Alireza Rezaiemanesh, Farhad Salari, Ali Gorgin Karaji   +4 more
doaj   +1 more source

Influence of Delivery Devices on Efficacy of Inhaled Fluticasone Propionate: A Comparative Study in Stable Asthma Patients [PDF]

Journal of Clinical and Diagnostic Research, 2013
Background: Inhaled corticosteroids are the preferred treatment for long-term control of all grades of persistent asthma. These are administered by various delivery devices with very little information whether these devices can affect the efficacy of
Bhanu Prakash Kolasani, Venu Madhavi Lanke, Sudheer Diyya   +2 more
doaj   +1 more source

Olopatadine Hydrochloride and Fluticasone Propionate in Topical Treatment of Allergic Rhinitis: A Single Blind Randomised Study [PDF]

Journal of Clinical and Diagnostic Research, 2016
Introduction: The use of corticosteroids or antihistaminics in treatment of allergic rhinitis is known and practiced since long. The efficacy of topical use of fluticasone propionate and Olopatadine Hydrochloride (HCL) for symptomatic relief of ...
Abhay Havle, Vishal Jain, MD Fazal Ahmed, Swapna Shedge, Vivek Dokania, Vikrant Bagwe, Ketan Agarwal   +6 more
doaj   +1 more source

The pan-JAK inhibitor LAS194046 reduces neutrophil activation from severe asthma and COPD patients in vitro

Scientific Reports, 2022
Non-T2 severe asthma and chronic obstructive pulmonary disease (COPD) are airway chronic inflammatory disorders with a poor response to corticosteroids.
Javier Milara, Beatriz Ballester, Alfredo de Diego, Marta Calbet, Isabel Ramis, Montserrat Miralpeix, Julio Cortijo   +6 more
doaj   +1 more source

Impact of inhaled corticosteroids on growth in children with asthma: systematic review and meta-analysis [PDF]

, 2015
Background: Long-term inhaled corticosteroids (ICS) may reduce growth velocity and final height of children with asthma. We aimed to evaluate the association between ICS use of >12 months and growth.
A Bush, AA Verberne, AB Becker, AC Ferguson, AI Pruteanu, Andrew M. Wilson, BJ Lipworth, C Acun, C Roux, CA Wong, DB Allen, DP Skoner, DP Skoner, DP Skoner, FE Simons, FM De Benedictis, G Jonasson, GA Rossi, GW Bensch, HW Kelly, J Gradman, JD Skoner, JF Price, JP Higgins, JP Ioannidis, JPT Higgins, JPT Higgins, L Agertoft, L Zhang, Luo Zhang, M Turpeinen, MD Silverstein, Menaka Thavarajah, ML Garcia Garcia, Patricia Blanco, PJ Merkus, RA Pauwels, S Pedersen, SA Gillman, YK Loke, YK Loke, Yoon Kong Loke   +41 more
core   +10 more sources

Effect of acupuncture therapy combined with fluticasone propionate in the treatment of persistent allergic rhinitis: study protocol for a randomized controlled trial

Trials, 2022
Background Allergic rhinitis (AR) is an immunoglobulin E (IgE)-mediated inflammatory response. Persistent allergic rhinitis (PAR) is a subtype of AR, but the treatment of PAR is still a problem.
Qi Fan, Yixuan Feng, Yan Hou, Feihu Wu, Wei Zhang, Wenbin Nie, Bin Li, Zhongyu Zhou, Wenbin Fu, Lei Shi, Zhongren Sun, Hong Zhao   +11 more
doaj   +1 more source